Mayo signs deal with Chinese firm
The Mayo Clinic name and services will soon be spreading to Asia.
Mayo Clinic Friday announced it has signed a deal with Valurise Health Solutions Inc., known as Haorensheng in China, to integrate components of Mayo Clinic's suite of Healthy Living services into its product line for employers and insurers in greater China, including the People's Republic of China, Hong Kong, Macau and Taiwan.
"We are excited to provide Mayo Clinic knowledge to the people of China, where the demand for high quality health and wellness offerings is growing rapidly. We welcome this opportunity to inform, inspire and partner with the people of China in their quest for better health," said Dr. Paul Limburg, medical director of the Mayo Clinic Office of Wellness.
As part of the deal, Mayo Clinic will provide its Ask Mayo Clinic triage algorithms; EmbodyHealth programs, tools and newsletters; health information content; Mayo Clinic Health Letter; and condition management content and materials.
VHS will be responsible for translating, culturally incorporating and integrating the Mayo Clinic content and knowledge into its products and services, and for marketing, selling, delivering and supporting the resulting products/services in China.
For its contribution to the collaboration, Mayo Clinic will receive equity in VHS and royalties over the multiyear term of the deal. Mayo Clinic and SAIF Partners, a leading growth venture capital fund, are investors in VHS.
"We aim to meet the phenomenal demand for chronic disease management and prevention programs in China," stated Dr. Rico W. Tang, CEO of VHS/Haorensheng. "Haorensheng is a leading brand in this rapidly expanding health risk management market and we represent the highest standard in China in providing innovative and one-stop health solutions.
Shanghai-based Haorensheng serves more than a million people from leading enterprise employers, government agencies and social security departments, it said.